Despite the coronavirus outbreak beginning in China, Beijing has brought it rapidly under control – the number of domestically transmitted cases was reduced to virtually zero by the end of March. In the US and Western Europe, on the contrary, the number of cases is rising vertiginously with no peak in sight. This disastrous US and Western European failure will be more severe than the international financial crisis and will have profound geopolitical consequences. The most fundamental issue was that China started from a real understanding of human rights as they affect the real lives of people – not the artificial constructs of Western, purely formal ‘human rights.’ In a lethal epidemic, the key human right is to stay alive. But what was the response of the so called ‘human rights’ organizations in the West to this? Total and criminal condemnation of China’s successful strategy!
Schengen is dead; it is the main victim of the coronavirus.
Where there is a serious threat to public policy or internal security, these countries may exceptionally reintroduce border controls at its internal borders for a period of no more than 30 days (possible to prolong under conditions established by the code) or for the foreseeable duration of the serious threat. This action should be seen as a last resort. If such controls are to be reintroduced, the other EU countries that are part of the Schengen area and the European Commission must be notified without delay with a view to possible consultations. The European Parliament and the Council must be informed at the same time.
The European Union is supporting Member States in addressing the crisis and has adopted measures to mitigate the economic consequences of the COVID-19 pandemic. To cushion the blow to people’s livelihoods and the economy, the European Commission has adopted a comprehensive economic response to the outbreak, applied the full flexibility of the EU fiscal rules, has revised its State Aid rules and proposed to set up a EUR 37 billion Coronavirus Response Investment Initiative to provide liquidity to small businesses and the health care sector. To support scientific research into COVID-19, the European Commission earmarked 47.5 million EUR for shortlisted research projects that can improve epidemiology and public health, including preparedness and response to outbreaks. The EU has also created first ever stockpile of medical equipment. Read more about the EU's response here and here. For similar cases, see here, here, and here.